Previously, we demonstrated that GSK-3β but not GSK-3α negatively regulates the functions of human NK cells triggered by multiple activating receptors, including NKG2D, 2B4, and NKp30, and against K562 CML cells [26]. This evidence concerns the gene KLRK1 and chronic myelogenous leukemia, BCR-ABL1 positive.